Dr Tomasz Pawinski
Warsaw Medical University
Warsaw
POLAND

March 23, 2007

Dear Dr Pawinski

Immunosuppressive Drugs Meeting
Warsaw – September 2008

As President of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology I am delighted that you have undertaken to organize the above meeting on our behalf. Our Association has had a sustained interest in the measurement of this group of drugs and I am sure that you will bring together a group of speakers able to summarise the very latest findings in this field.

On behalf of our Association I wish you all success and our full support for the event.

Best wishes

David W Holt
President
IATDMCT 2005 - 2007

Warsaw, 6 February 2006

Dr Tomasz Pawiński, DPharm
Chairman of the Organising Committe

Dear Doctor Pawiński,
I would like to expressmy thanks for inviting me to take patronage over the Conference "Therapeutic Drug Monitoring in Optimizing the Immunosuppressive Therapy".

Appropriate treatment after transplantation is very significant in nowadays. Transplantation is only the first step in complete recovery of the patient. Immunosuppressive drugs play an important role in the process. It is our obligation to obtine every possible knowledge on such drugs.

Therefore, I am pleased to inform you that it is my honour to take the Conference "Therapeutic Drug Monitoring in Optimizing the Immunosuppressive Therapy" under my patronage.

I do believe that this Conference will contribute to the increase of efficiency in the treatment of patients.

Sincerely Yours
Prof. Leszek Pączek, MD PhD
Rector

Bruxelles, le 27/12/2005

Service de Biochime médicaie

Chimie automatisée
  Prof. M. Philippe
  Dr D.Maisin

Biochimie analityque
  Toxicologie et chimie spéciale
  Prof. P. Wallemacq

  Toxicologie industrielle et environnementale
  Dr V. Haufroidbr

  Maladies métabolicques et biologie moléculaire
  Prof. M.F. Vincent
  Prof. M. Philippe

  Stéroides et catécholamines
  Prof J.M. Ketelslegers
  Dr V. Haufroid

On behalf on the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT), and as Chairman of the Immunosuppressive Drug Committee, I fully support the project of Drs Tomasz Pawinski and Pawel Kunicki, in the organization of a conference session on "Therapeutic Drug Monitoring in optimising the immunosuppressive therapy" in September 2008 in Warsaw.

There is no doubt that the strategic central location of Warsaw together with an excellent scientific progam will attract number of scientists and experts in the field of transplantation and immunosuppression from all central-east Europe.